Raelipskie Partnership’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-448
Closed -$3.14K – 125
2025
Q4
$3.14K Hold
448
– – ﹤0.01% 101
2025
Q3
$3.46K Hold
448
– – ﹤0.01% 99
2025
Q2
$3.9K Hold
448
– – ﹤0.01% 98
2025
Q1
$3.57K Hold
448
– – ﹤0.01% 99
2024
Q4
$4.07K Hold
448
– – ﹤0.01% 99
2024
Q3
$4.11K Buy
+448
New +$3.71K ﹤0.01% 109

Other funds holding TDOC

Raelipskie Partnership's TDOC Position: Q1 2026 in Review

Raelipskie Partnership sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 448 shares — an estimated $3.14K sold.

Raelipskie Partnership first reported a position in TDOC in Q3 2024 and held it in 6 quarters. The position peaked at $4.11K in Q3 2024. 325 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Raelipskie Partnership reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
  • Raelipskie Partnership sold 448 Teladoc Health shares in Q1 2026, an estimated $3.14K.
  • Raelipskie Partnership first reported a position in Teladoc Health in Q3 2024 and held it in 6 quarters.
  • Raelipskie Partnership's Teladoc Health position peaked at $4.11K in Q3 2024.
  • 325 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Raelipskie Partnership's 13F filing for Q1 2026, filed 29 Apr 2026.